Loading...
XSWX
BANB
Market cap5.02bUSD
Dec 04, Last price  
53.85CHF
1D
-1.73%
1Q
-15.33%
Jan 2017
-40.37%
IPO
-48.84%
Name

Bachem Holding AG

Chart & Performance

D1W1MN
XSWX:BANB chart
P/E
33.58
P/S
6.67
EPS
1.60
Div Yield, %
1.49%
Shrs. gr., 5y
1.62%
Rev. gr., 5y
14.05%
Revenues
605m
+4.84%
153,656,000171,754,000198,318,000194,997,000181,848,000152,884,000145,808,000157,298,000170,685,000183,937,000208,604,000236,478,000261,612,000282,500,000313,715,000401,995,000503,234,000531,741,000577,316,000605,259,000
Net income
120m
+7.50%
39,232,00046,649,00063,927,00058,709,00046,057,00028,297,0009,409,00015,300,00023,604,00029,065,00031,838,00041,205,00041,770,00046,644,00054,164,00078,062,000114,682,000100,684,000111,859,000120,248,000
CFO
146m
-41.44%
27,423,00040,150,00078,070,00039,277,00042,847,00038,110,00024,609,00036,871,00049,230,00047,218,00061,434,00040,409,00036,479,00025,776,00063,648,000114,628,00097,163,00092,589,000249,864,000146,322,000
Dividend
May 05, 20250 CHF/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland.
URL
https://www.bachem.com/
IPO date
Jun 29, 2001
Employees
1,926
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT